Artwork

Content provided by Pink Elephant Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pink Elephant Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why Psychedelic Startups Hit a Wall? Ronan Levy on Field Trip’s Rise, Ketamine Clinics & What’s Next

49:36
 
Share
 

Manage episode 496614585 series 3679834
Content provided by Pink Elephant Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pink Elephant Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Today’s guest is Ronan Levy, co-founder and former CEO of Field Trip Health, joins Jason Najum to reflect on the explosive rise and collapse of one of the first public psychedelic therapy companies.
#PsychedelicStartups #KetamineClinics #mentalhealthinnovation
#mentalhealthpodcast
In this raw and insightful conversation, Ronan shares:
- How Field Trip raised $100M and listed on the NASDAQ
- Why psychedelic therapy clinics are hard to scale
- What went wrong with the ketamine clinic model
- The truth about FDA rejection and psychedelic drug development
- How Ronan sees the future of mental health, psychedelic therapy, and functional alternatives to alcohol
00:00 – Intro: The rise and fall of Field Trip Health
01:30 – Ronan Levy's journey: from law to cannabis to psychedelics
06:30 – Launching Field Trip during the psychedelic gold rush
10:30 – Building a brand that stood out in a clinical space
14:30 – NASDAQ listing, media buzz, and mounting pressure
18:00 – Why ketamine clinics failed to scale
25:30 – Lessons from the crash: what Ronan would do differently
32:00 – Can psychedelics be a scalable business?
37:00 – The future: decentralization, community care, and human connection
44:00 – Ronan’s new venture: alcohol alternatives that actually feel good
47:30 – Final thoughts: what’s next for psychedelic mental health
Whether you're an entrepreneur, therapist, investor, or just curious about the psychedelic renaissance—this episode offers a rare inside look.
Like what you heard? Hit subscribe and follow us on YouTube @Evolvong_Minds_Podcast for more in-depth insights into the future of mental health.
---------------------------------------------
The Evolving Minds podcast by Pink Elephant, hosted by Jason Najum, is a series of 1-on-1 conversations with star guests who dare to build, scale, or rethink companies, policies, and protocols at the frontier of progressive mental health.

  continue reading

One episode

Artwork
iconShare
 
Manage episode 496614585 series 3679834
Content provided by Pink Elephant Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pink Elephant Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Today’s guest is Ronan Levy, co-founder and former CEO of Field Trip Health, joins Jason Najum to reflect on the explosive rise and collapse of one of the first public psychedelic therapy companies.
#PsychedelicStartups #KetamineClinics #mentalhealthinnovation
#mentalhealthpodcast
In this raw and insightful conversation, Ronan shares:
- How Field Trip raised $100M and listed on the NASDAQ
- Why psychedelic therapy clinics are hard to scale
- What went wrong with the ketamine clinic model
- The truth about FDA rejection and psychedelic drug development
- How Ronan sees the future of mental health, psychedelic therapy, and functional alternatives to alcohol
00:00 – Intro: The rise and fall of Field Trip Health
01:30 – Ronan Levy's journey: from law to cannabis to psychedelics
06:30 – Launching Field Trip during the psychedelic gold rush
10:30 – Building a brand that stood out in a clinical space
14:30 – NASDAQ listing, media buzz, and mounting pressure
18:00 – Why ketamine clinics failed to scale
25:30 – Lessons from the crash: what Ronan would do differently
32:00 – Can psychedelics be a scalable business?
37:00 – The future: decentralization, community care, and human connection
44:00 – Ronan’s new venture: alcohol alternatives that actually feel good
47:30 – Final thoughts: what’s next for psychedelic mental health
Whether you're an entrepreneur, therapist, investor, or just curious about the psychedelic renaissance—this episode offers a rare inside look.
Like what you heard? Hit subscribe and follow us on YouTube @Evolvong_Minds_Podcast for more in-depth insights into the future of mental health.
---------------------------------------------
The Evolving Minds podcast by Pink Elephant, hosted by Jason Najum, is a series of 1-on-1 conversations with star guests who dare to build, scale, or rethink companies, policies, and protocols at the frontier of progressive mental health.

  continue reading

One episode

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play